PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma

Conditions

• NK-T-Cell Lymphoma, Extranodal

Interventions

• DRUG: 4 cycles of ESA regimen with sandwiched radiotherapy
• DRUG: 2 cycles of ESA regimen sequential radiotherapy and 2 cycles of PD-1 monoclonal antibody combined with pegaspargase
• DRUG: 2 cycles of ESA regimen, 2 cycles of PD-1 monoclonal antibody and concurrent radiotherapy, 2 cycles of PD-1 monoclonal antibody combined with pegaspargase

Sponsor

Ruijin Hospital